The OpenPlant Forum provides a platform for exploring the potential applications of reprogrammed biological systems, and a framework for exploring the wider implications of the potentially disruptive new technologies. The Forum is held annually, in the last week of July, alternating between Cambridge and Norwich. (We welcome attendees from outside OpenPlant).
Previous OpenPlant Forums
Fast & Frugal Biotechnology 2017
The 2017 OpenPlant Forum provided a showcase for new technical developments in lyophilised cell-free systems and curriculum development, which allow gene expression experiments in low resource environments with poor access to refrigeration and containment facilities. Invited speakers were: Jim Swartz (Stanford), Keith Pardee (University of Toronto), Sebastian Maerkl (EPFL), Simon Moore (Imperial College), Simon Moore (Imperial College), Maneshree Jugmohan-Naidu (South African National Department of Science and Technology), Simon Trace (Oxford Policy Management), Lara Allen (Centre for Global Equality), Fiona Robertson (University of Zimbabwe), Jake Wintermute (CRI Paris), Karen Ingram (Artist), Helene Steiner (Microsoft Research), Mario Arteaga (Universidad Veracruzana), Dan Jenkins (Science and Plants for Schools).
Reprogramming Agriculture 2016
The 2016 OpenPlant Forum was based on the theme of "Reprogramming Agriculture", with invited keynote talks from Allan Green (CSIRO, Australia), Johnathan Napier (Rothamsted Research) Patrick Jarvis (AB Sugar, Wissington), Dominic Berry (University of Edinburgh), Spencer Adler (Bioeconomy Capital), Tom Knight (Ginkgo Bioworks), Peter Murray-Rust (ContentMine, Cambridge), commentary from Monique Simmonds (Kew Gardens), Wieke Betten (University of Amsterdam) and industry perspectives from Leaf Systems, NCG:Earlham Institute, OxSyBio, Cambridge Consultants, Rainbow Seed Fund/Midven, and Plant Bioscience.
Openness & Innovation 2015
The 2015 OpenPlant Forum explored a theme of "Openness & Innovation", with keynote presentations from external speakers Tom Knight (Ginkgo Bioworks), Randy Rettberg (iGEM Foundation), Jane Calvert (University of Edinburgh), David Rejeski (Woodrow Wilson Center), Linda Kahl (BioBricks Foundation), Marcus Gershater (Synthace), Chas Boundra (University of Oxford), Rob Mullins (Raspberry Pi & University of Cambridge), invited commentary from Drew Endy (Stanford) and industry perspectives from Twist Bioscience, Bactevo, Sphere Fluidics, Isomerase Therapeutics and SynBioBeta.